State Out-Of-Pocket Caps On Insulin Costs: No Significant Increase In Claims Or Utilization
Health Affairs · 2024
DOI: 10.1377/hlthaff.2024.00118 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Affairs, 2024. Verfasst von Kelly E Anderson und 6 weiteren Autor:innen. Beteiligte Einrichtung: Kelly E. Anderson (Kelly.E.Anderson@cuanschutz.edu), University of Colorado Anschutz Medical Campus, Aurora, Colorado. Hauptthemen laut MEDLINE: Insulin, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1, Health Expenditures. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: AHRQ HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Nearly all patients with type 1 diabetes and 20-30 percent of patients with type 2 diabetes use insulin to manage glycemic control. Approximately one-quarter of patients who use insulin report underuse because of cost. In response, more than twenty states have implemented monthly caps on insulin out-of-pocket spending, ranging from $25 to $100. Using a difference-in-differences approach, this study evaluated whether state-level caps on insulin out-of-pocket spending change insulin usage among commercially insured enrollees. The study included 33,134 people ages 18-64 who had type 1 diabetes or who used insulin to manage type 2 diabetes with commercial insurance coverage that was subject to state-level oversight and was included in the 25 percent sample of the IQVIA PharMetrics database during 2018-21. Insulin out-of-pocket caps did not significantly increase quarterly insulin claims for enrollees who had type 1 diabetes or who used insulin to manage type 2 diabetes. State-level caps on insulin out-of-pocket spending for commercial enrollees did not significantly increase insulin use; that may be in part because of out-of-pocket expenses being lower than cap amounts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Kelly E. Anderson (Kelly.E.Anderson@cuanschutz.edu), University of Colorado Anschutz Medical Campus, Aurora, Colorado.
- Nathorn Chaiyakunapruk, University of Utah, Salt Lake City, Utah.
- Eric J. Gutierrez, University of Colorado Anschutz Medical Campus.
- H. Weston Schmutz, University of Utah.
- Michael R. Rose, Johns Hopkins University, Baltimore, Maryland.
- Diana Brixner, University of Utah.
Förderung
- AHRQ HHS
- NCATS NIH HHS
Zitieren
APA
Anderson, K. E., Chaiyakunapruk, N., Gutierrez, E. J., Schmutz, H. W., Rose, M. R., Brixner, D., & McQueen, R. B. (2024). State Out-Of-Pocket Caps On Insulin Costs: No Significant Increase In Claims Or Utilization. Health Affairs. https://doi.org/10.1377/hlthaff.2024.00118
Vancouver
Anderson KE, Chaiyakunapruk N, Gutierrez EJ, Schmutz HW, Rose MR, Brixner D, et al. State Out-Of-Pocket Caps On Insulin Costs: No Significant Increase In Claims Or Utilization. Health Affairs. 2024. doi:10.1377/hlthaff.2024.00118
BibTeX
@article{Anderson2024,
author = {Anderson, Kelly E and Chaiyakunapruk, Nathorn and Gutierrez, Eric J and Schmutz, H Weston and Rose, Michael R and Brixner, Diana and McQueen, R Brett},
title = {State Out-Of-Pocket Caps On Insulin Costs: No Significant Increase In Claims Or Utilization},
journal = {Health Affairs},
year = {2024},
doi = {10.1377/hlthaff.2024.00118}
}
EUVIMED